Nine of them (TMEM106B, EPHA1, CD2AP, CHRNE, MPO, BIN1, MS4A6A, EPHX2, and MAPK3) were enriched in neurological disease categories including four dementia and AD categories (P values ranged from 4.94 × 10-2 to 7.25 × 10-5). This evidence concerns the gene MPO and nervous system disorder.